Policy
Changes
Dashboard
Pricing
Sign in
Sign up free
Home
/
Changes
/
Medicare/CMS - LCD
/
MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
Back to dashboard
All Plans
Administrative
Medium impact
MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
Medicare/CMS - LCD
·
Local Coverage Determination
Effective date
Not stated
We identified it
Jul 10, 2026
Days to comply
—
Summary
Failed to analyze policy change
Action Required
Action needed
Manual review required
Related policy hubs
Medicare/CMS - LCD policies